Видео ютуба по тегу Biocon Growth

Biocon’s Big Bet: GLP-1 & Insulin Drive The Next Growth Wave | Kiran Mazumdar-Shaw | Business News
Biocon’s Big Bet: GLP-1 & Insulin Drive The Next Growth Wave | Kiran Mazumdar-Shaw | Business News
Biocon Biologics CEO: Integration To Boost Value, Balance Sheet & Competitiveness | Business News
Biocon Biologics CEO: Integration To Boost Value, Balance Sheet & Competitiveness | Business News
Biocon Equity Raise, Anand Rathi AUM Growth, HDFC Bank Valuations & Top Sector Picks | Business News
Biocon Equity Raise, Anand Rathi AUM Growth, HDFC Bank Valuations & Top Sector Picks | Business News
Biocon Income Analysis | Stock Analysis 2025 | Revenue, Profit Trends, EPS Growth & Pharma Outlook
Biocon Income Analysis | Stock Analysis 2025 | Revenue, Profit Trends, EPS Growth & Pharma Outlook
Generics Growth Aided By Other Drugs Besides Liraglutide & API Biz: Biocon | CNBC TV18
Generics Growth Aided By Other Drugs Besides Liraglutide & API Biz: Biocon | CNBC TV18
Strong Biosimilar Growth Powers Biocon | Trading Hour | CNBC TV18
Strong Biosimilar Growth Powers Biocon | Trading Hour | CNBC TV18
2024: A Year of Milestones, Growth, and Impact at #Biocon!
2024: A Year of Milestones, Growth, and Impact at #Biocon!
BIOCON: Искусственный интеллект прогнозирует влияние инновационного процесса на выручку после 202...
BIOCON: Искусственный интеллект прогнозирует влияние инновационного процесса на выручку после 202...
Expect Growth To Come From Biosimilars: Biocon
Expect Growth To Come From Biosimilars: Biocon
Biocon Gets US FDA Approval for Everolimus Tablets: Key Growth Trigger Explained
Biocon Gets US FDA Approval for Everolimus Tablets: Key Growth Trigger Explained
How Biocon’s Bold Move Transformed India’s Biotech Industry | Kiran Mazumdar-Shaw's Vision
How Biocon’s Bold Move Transformed India’s Biotech Industry | Kiran Mazumdar-Shaw's Vision
Dr. Abhijit Barve, President, Research & Development, Biocon
Dr. Abhijit Barve, President, Research & Development, Biocon
Biocon: U.S., European Markets Aided Growth In Q2
Biocon: U.S., European Markets Aided Growth In Q2
Biocon Sees Two Segments Driving Its Growth In 2019-20: #Q1WithBQ
Biocon Sees Two Segments Driving Its Growth In 2019-20: #Q1WithBQ
Endobacteria May Influence Broccoli Sprout Growth and Glucosinolate Production - Biocon 2021
Endobacteria May Influence Broccoli Sprout Growth and Glucosinolate Production - Biocon 2021
Demystifying Science: Cell Culture (Upstream Processing)
Demystifying Science: Cell Culture (Upstream Processing)
Biocon Biologics reports A 29% YoY Growth For Q1FY23 With Revenues At ₹977 Cr
Biocon Biologics reports A 29% YoY Growth For Q1FY23 With Revenues At ₹977 Cr
Biocon Biologics' transformational milestones in 2022.
Biocon Biologics' transformational milestones in 2022.
Biocon Appoints Peter Bains As Group CEO To Drive 'Synergistic' Growth: What's The Road Ahead?
Biocon Appoints Peter Bains As Group CEO To Drive 'Synergistic' Growth: What's The Road Ahead?
Exclusive | Biocon Biologics Q4: Serum Will Double Investment To $300 Mn
Exclusive | Biocon Biologics Q4: Serum Will Double Investment To $300 Mn